The prescription drug or “pharmacy” value chain is complex and involves many parties. Manufacturer rebates are particularly complex, and rebates must be accounted for to understand payers’ true cost of prescription drugs. Failing to account for rebates overstates the net impact of pharmacy costs to a payer’s total costs.

This article was commissioned by Merck, Inc.